Mark Boguniewicz
Allergy · Denver, CONPI 1790796555
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $534,088 of the $813,807 with a category attached, or 65.6%. It is spread thinly across 26 manufacturers, the largest accounting for just 21.0%. Reporting peaked in 2019 at $286,417 and has fallen 85.3% since, to $41,971 in 2025.
Across 669 payments — averaging $1216.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$171K
- Sanofi$158K
- Eli Lilly$75K
- Pfizer$61K
- Sanofi-aventis U.S. LLC$61K
- Regeneron$55K
- plus $233K from 20 others
Across 332 payments — averaging $1039.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$307K
- Pfizer$23K
- Incyte Corporation$8K
- Sanofi$7K
What the payments were for
- Consulting fees$534,08866%
- Speaking & faculty fees$135,69517%
- Travel & lodging$130,49716%
- Food & beverage$13,5272%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 157 | $170,772 |
| Sanofi | 82 | $157,848 |
| Eli Lilly | 99 | $75,242 |
| Pfizer | 32 | $61,049 |
| Sanofi-aventis U.S. LLC | 23 | $60,955 |
| Regeneron | 38 | $55,092 |
| AbbVie | 54 | $45,225 |
| LEO Pharma Inc. | 21 | $43,272 |
| Dermavant Sciences, Inc. | 50 | $38,719 |
| Incyte Corporation | 25 | $25,382 |
| UCB SA | 11 | $18,172 |
| LEO Pharma AS | 4 | $14,563 |
| Amgen | 11 | $11,280 |
| Arcutis Biotherapeutics, Inc. | 11 | $8,107 |
| Dermira, Inc. | 10 | $7,837 |
| GSK | 2 | $6,096 |
| Janssen Global Services, LLC | 2 | $4,860 |
| Lilly USA, LLC | 12 | $4,651 |
| Janssen Research & Development, LLC | 1 | $2,160 |
| Organon | 12 | $1,678 |
| Alk-abello, Inc | 3 | $253 |
| AstraZeneca | 4 | $244 |
| ADMA Biomanufacturing LLC | 1 | $173 |
| Pharming Healthcare, Inc. | 2 | $143 |
| Genentech USA, Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few allergy providers in Coloradoto place this figure against a meaningful peer group, so we don't.
Other allergy in Denver
- Nathanael BradyColorado Springs$971K
- Daniel SoteresColorado Springs$650K
- Regan PyleAvon$72K
- William LantingFort Collins$36K
- Christianne McGrathColorado Springs$11K
- Carmen LaronnCentennial$844
- William SilversCentennial$160
- Mark MenichBoulder$132
- Karen AndrewsBoulder$132
- Kirstin CarelAurora$36
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.